Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway

BACKGROUND: The increase in the levels of reactive oxygen species (ROS) in acute myeloid leukemia (AML) patients has been previously described; thus, it is important to regulate ROS levels in AML. METHODS: Flow cytometry were used to assess the in vitro effect of compound kushen injection (CKI). Qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yanxia, Yang, Qian, Liang, Li, Ding, Lu, Liang, Yuxing, Zhang, Dongdong, Wu, Balu, Yang, Tian, Liu, Hailing, Huang, Tingting, Shen, Hui, Tu, Honglei, Pan, Yunbao, Wei, Yongchang, Yang, Yi, Zhou, Fuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245615/
https://www.ncbi.nlm.nih.gov/pubmed/30454068
http://dx.doi.org/10.1186/s13046-018-0948-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245615/
https://www.ncbi.nlm.nih.gov/pubmed/30454068
http://dx.doi.org/10.1186/s13046-018-0948-3

Ejemplares similares